9805 related articles for article (PubMed ID: 1542095)
1. Novel anticancer prodrugs of butyric acid. 2.
Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A
J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095
[TBL] [Abstract][Full Text] [Related]
2. Derivatives of butyric acid as potential anti-neoplastic agents.
Rephaeli A; Rabizadeh E; Aviram A; Shaklai M; Ruse M; Nudelman A
Int J Cancer; 1991 Aug; 49(1):66-72. PubMed ID: 1874573
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of tributyrin in murine melanoma model.
Giermasz A; Nowis D; Jalili A; Basak G; Marczak M; Makowski M; Czajka A; Młynarczuk I; Hoser G; Stok osa T; Lewandowski S; Jakóbisiak M
Cancer Lett; 2001 Mar; 164(2):143-8. PubMed ID: 11179828
[TBL] [Abstract][Full Text] [Related]
4. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug.
Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A
FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968
[TBL] [Abstract][Full Text] [Related]
5. The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.
Rephaeli A; Entin-Meer M; Angel D; Tarasenko N; Gruss-Fischer T; Bruachman I; Phillips DR; Cutts SM; Haas-Kogan D; Nudelman A
Invest New Drugs; 2006 Sep; 24(5):383-92. PubMed ID: 16502348
[TBL] [Abstract][Full Text] [Related]
6. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
Nudelman A; Rephaeli A
J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204
[TBL] [Abstract][Full Text] [Related]
7. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
[TBL] [Abstract][Full Text] [Related]
8. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
9. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy.
Pouillart P; Cerutti I; Ronco G; Villa P; Chany C
Int J Cancer; 1991 Aug; 49(1):89-95. PubMed ID: 1874576
[TBL] [Abstract][Full Text] [Related]
10. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
11. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A
Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseases.
Nudelman A; Gnizi E; Katz Y; Azulai R; Cohen-Ohana M; Zhuk R; Sampson SR; Langzam L; Fibach E; Prus E; Pugach V; Rephaeli A
Eur J Med Chem; 2001 Jan; 36(1):63-74. PubMed ID: 11231050
[TBL] [Abstract][Full Text] [Related]
13. The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties.
Blank-Porat D; Gruss-Fischer T; Tarasenko N; Malik Z; Nudelman A; Rephaeli A
Cancer Lett; 2007 Oct; 256(1):39-48. PubMed ID: 17611019
[TBL] [Abstract][Full Text] [Related]
14. Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.
Cutts SM; Nudelman A; Pillay V; Spencer DM; Levovich I; Rephaeli A; Phillips DR
Oncol Res; 2005; 15(4):199-213. PubMed ID: 17822280
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
Xia Z; Wiebe LI; Miller GG; Knaus EE
Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: a preclinical study.
Coradini D; Pellizzaro C; Abolafio G; Bosco M; Scarlata I; Cantoni S; Stucchi L; Zorzet S; Turrin C; Sava G; Perbellini A; Daidone MG
Invest New Drugs; 2004 Aug; 22(3):207-17. PubMed ID: 15122068
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
del Olmo M; Alonso-Varona A; Castro B; Calle Y; Bilbao P; Palomares T
Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
[TBL] [Abstract][Full Text] [Related]
18. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.
Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A
J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880
[TBL] [Abstract][Full Text] [Related]
19. Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation.
Berkovitch G; Doron D; Nudelman A; Malik Z; Rephaeli A
J Med Chem; 2008 Dec; 51(23):7356-69. PubMed ID: 19007111
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
